Free Trial

Short Interest in Sysmex Co. (OTCMKTS:SSMXY) Grows By 96.2%

Sysmex logo with Medical background

Sysmex Co. (OTCMKTS:SSMXY - Get Free Report) was the target of a significant growth in short interest in November. As of November 15th, there was short interest totalling 10,200 shares, a growth of 96.2% from the October 31st total of 5,200 shares. Based on an average daily trading volume, of 103,400 shares, the days-to-cover ratio is presently 0.1 days.

Sysmex Price Performance

Shares of OTCMKTS:SSMXY traded up $0.47 during midday trading on Friday, hitting $21.14. The company had a trading volume of 36,484 shares, compared to its average volume of 103,938. The business's 50-day simple moving average is $19.51 and its 200-day simple moving average is $18.02. The stock has a market cap of $13.30 billion, a price-to-earnings ratio of 40.80 and a beta of 0.84. The company has a debt-to-equity ratio of 0.11, a current ratio of 3.23 and a quick ratio of 2.40. Sysmex has a twelve month low of $14.38 and a twelve month high of $29.78.

About Sysmex

(Get Free Report)

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

Recommended Stories

Should you invest $1,000 in Sysmex right now?

Before you consider Sysmex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.

While Sysmex currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

(Almost)  Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Amazon’s AI Power and Holiday Boost Make This Stock a 2025 Winner
Small Caps, Financials & Bitcoin Lead the Rising Bull Market: Chris Rowe’s Top Picks
MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines